Your session is about to expire
← Back to Search
Behavioral Intervention
Deep Brain Reorienting for Post-Traumatic Stress Disorder
N/A
Recruiting
Led By Ruth A Lanius, MD, PhD
Research Sponsored by London Health Sciences Centre Research Institute and Lawson Research Institute of St. Joseph's
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Age between 18 and 65
Be older than 18 years old
Must not have
Current participation in counseling more extensive than supportive therapy (e.g., exposure therapy, Cognitive-Behavioral Therapy would be an exclusion)
History of neurological disorder
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights
No Placebo-Only Group
Summary
This trial will test whether Deep Brain Reorienting (DBR) is an effective treatment for PTSD. Participants will be assigned to either the DBR treatment or a wait-list condition.
Who is the study for?
This trial is for English-speaking adults aged 18-65 with PTSD who might gain from short-term trauma therapy. It's not for those with implants or conditions unsafe for high-strength fMRI, significant head injuries, untreated major illnesses, neurological disorders, extensive current counseling (like exposure therapy), severe mental distress unsuitable for brief treatment, developmental disorders, bipolar or psychotic history, or recent substance abuse.
What is being tested?
The study tests Deep Brain Reorienting (DBR) as a treatment for PTSD. Participants will be randomly assigned to either receive DBR therapy or placed on a wait-list as part of the control group to compare outcomes between the two sets.
What are the potential side effects?
While specific side effects are not listed here due to the nature of psychological interventions like DBR being less likely to have physical side effects compared to medication-based treatments; participants may experience emotional discomfort during sessions.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am between 18 and 65 years old.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I am not currently in any intensive counseling like CBT or exposure therapy.
Select...
I have a history of a neurological disorder.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 3 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
change in PTSD symptoms from baseline as measured by the Clinician Administered PTSD Scale (CAPS) at post-treatment assessment
change in PTSD symptoms from post-treatment assessment as measured by the Clinician Administered PTSD Scale (CAPS) at follow-up assessment
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: DBR ConditionExperimental Treatment1 Intervention
Involves 8 weekly sessions of DBR treatment.
Group II: Wait-list ConditionActive Control1 Intervention
No intervention for approximately 8 weeks.
Find a Location
Who is running the clinical trial?
London Health Sciences Centre Research Institute and Lawson Research Institute of St. Joseph'sLead Sponsor
319 Previous Clinical Trials
347,225 Total Patients Enrolled
Lawson Health Research InstituteLead Sponsor
683 Previous Clinical Trials
431,296 Total Patients Enrolled
Canadian Institutes of Health Research (CIHR)OTHER_GOV
1,392 Previous Clinical Trials
26,527,342 Total Patients Enrolled
Ruth A Lanius, MD, PhDPrincipal InvestigatorLondon Health Sciences Centre Research Institute and Lawson Research Institute of St. Joseph's
1 Previous Clinical Trials